Drug Prices by Pharmaceutical Manufacturer

DrugPrice tracks 45 pharmaceutical manufacturers with drugs in the Medicare Part D program. Only companies with at least 2 tracked drugs are included on this index.

Bristol-Myers Squibb leads with $39.5B in annual Medicare Part D spending across 20 drugs.

After patents expire, multiple generic manufacturers can produce bioequivalent versions of the same drug. The original brand (e.g. Lipitor) and its generic (atorvastatin) are often sold under different manufacturer names, but the FDA certifies them as therapeutically equivalent.

Manufacturer names come from FDA labeling data and the CMS Medicare Part D spending dataset. In some cases, drugs are marketed by one company but manufactured by another under contract — the labeler of record is shown here.